No effect of bone morphogenetic protein-7 (OP-1) on the incorporation of impacted bone grafts in a realistic acetabular model

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 84, Issue 1, 2008, Pages 231-239

  Buma, Pieter ^a   Arts, J J Chris ^a   Gardeniers, Jean W M ^a   Verdonschot, Nico ^a   Schreurs, B Willem ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Animal model; Bone conduction; Bone impaction grafting; Hip; OP 1; Osteoclast; Reconstructive surgery

Indexed keywords

ANIMAL MODEL; BONE CONDUCTION; BONE DEFECTS; BONE GRAFTS; BONE MORPHOGENETIC PROTEIN; RECONSTRUCTIVE SURGERY; REVASCULARIZATION PROCESS;

BONE; HIP PROSTHESES; IMPLANTS (SURGICAL);

PROTEINS;

BONE CEMENT; BONE MORPHOGENETIC PROTEIN; COLLAGEN; MONOMER; POLYETHYLENE; PROCOLLAGEN C PROTEINASE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 1; UNCLASSIFIED DRUG;

ACETABULUM; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GRAFT; BONE REMODELING; BONE SCREW; CANCELLOUS BONE; DOSE RESPONSE; ENCHONDRAL OSSIFICATION; FEMUR; FRACTURE; GAMMA IRRADIATION; GOAT; HIP PROSTHESIS; HIP RADIOGRAPHY; HIP SURGERY; HISTOLOGY; IMPACTED MORSELLIZED CANCELLOUS BONE GRAFT; NONHUMAN; ORTHOPEDIC SURGERY; OSTEOCLAST; PELVIS; POSTOPERATIVE INFECTION; STERNUM; SURGICAL EQUIPMENT; TISSUE REACTION; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; VASCULARIZATION;

ACETABULUM; ANIMALS; BONE CEMENTS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; BONE RESORPTION; BONE TRANSPLANTATION; FEMALE; GOATS; MODELS, BIOLOGICAL; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTS;

EID: 37549052558     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30865     Document Type: Article

References (39)

1. Herberts P, Malchau H. Long-term registration has improved the quality of hip replacement: A review of the Swedish THR Register comparing 160,000 cases. Acta Orthop Scand 2000; 71:111-121.
2. Maloney WJ, Paprosky W, Engh CA, Rubash H. Surgical treatment of pelvic osteolysis. Clin Orthop Relat Res 2001; 393:78-84.
3. Maloney WJ, Wadey VM. Management of acetabular bone loss. Instr Course Lect 2006;55:279-285.
4. Slooff TJ, Huiskes R, van Horn J, Lemmens AJ. Bone grafting in total hip replacement for acetabular protrusion. Acta Orthop Scand 1984;55:593-596.
5. Gross AE. Revision arthroplasty of the acetabulum with restoration of bone stock. Clin Orthop Relat Res 1999;369:198-207.
6. Ornstein E. Hip revisions with impacted morselized allograft bone and cement. Patient outcome, prosthetic fixation and risks. Acta Orthop Scand Suppl 2002;73:1-66.
7. Schreurs BW, Bolder SB, Gardeniers JW, Verdonschot N, Slooff TJ, Veth RP. Acetabular revision with impacted morsellised cancellous bone grafting and a cemented cup. A 15-to 20-year follow-up. J Bone Joint Surg Br 2004;86:492-497.
8. Schimmel JW, Buma P, Versleyen D, Huiskes R, Slooff TJ. Acetabular reconstruction with impacted morselized cancellous allografts in cemented hip arthroplasty: A histological and biomechanical study on the goat. J Arthroplasty 1998;13: 438-448.
9. Buma P, Lamerigts N, Schreurs BW, Gardeniers J, Versleyen D, Slooff TJ. Impacted graft incorporation after cemented acetabular revision. Histological evaluation in 8 patients. Acta Orthop Scand 1996;67:536-540.
10. Heekin RD, Engh CA, Vinh T. Morselized allograft in acetabular reconstruction. A postmortem retrieval analysis. Clin Orthop Relat Res 1995;319:184-190.
11. Van Der Donk S, Buma P, Slooff TJ, Gardeniers JW, Schreurs BW. Incorporation of morselized bone grafts: A study of 24 acetabular biopsy specimens. Clin Orthop 2002; 396:131-141.
12. Boden SD. The ABCs of BMPs. Orthop Nurs 2005;24:49-52.
13. Cullinane DM, Lietman SA, Inoue N, Deitz LW, Chao EY. The effect of recombinant human osteogenic protein-1 (bone morphogenetic protein-7) impregnation on allografts in a canine intercalary bone defect. J Orthop Res 2002;20:1240-1245.
14. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001;83A(Suppl 1):S151-S158.
15. Geesink RG, Hoefnagels NH, Bulstra SK. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 1999;81:710-718.
16. Lind M, Overgaard S, Song Y, Goodman SB, Bunger C, Soballe K. Osteogenic protein 1 device stimulates bone healing to hydroxyapaptite-coated and titanium implants. J Arthroplasty 2000;15:339-346.
17. Margolin MD, Cogan AG, Taylor M, Buck D, McAllister TN, Toth C, McAllister BS. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J Periodontol 1998;69:911-919.
18. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 2001;83A:803-816.
19. Soballe K, Jensen TB, Mouzin O, Kidder L, Bechtold JE. Differential effect of a bone morphogenetic protein-7 (OP-1) on primary and revision loaded, stable implants with allograft. J Biomed Mater Res A 2004;71:569-576.
20. Vaccaro AR, Patel T, Fischgrund J, Anderson DG, Truumees E, Herkowitz H, Phillips F, Hilibrand A, Albert TJ. A 2-year follow-up pilot study evaluating the safety and efficacy of OP-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions. Eur Spine J 2005;14:623-629.
21. Tagil M, Aspenberg P. Impaction of cancellous bone grafts impairs osteoconduction in titanium chambers. Clin Orthop 1998;352:231-238.
22. Tagil M, Jeppsson C, Aspenberg P. Bone graft incorporation. Effects of osteogenic protein-1 and impaction. Clin Orthop 2000;371:240-245.
23. Tagil M, Jeppsson C, Wang JS, Aspenberg P. No augmentation of morselized and impacted bone graft by OP-1 in a weight-bearing model. Acta Orthop Scand 2003;74:742-748.
24. Barrack RL, Cook SD, Patron LP, Salkeld SL, Szuszczewicz E, Whitecloud TS. Induction of bone ingrowth from acetabular defects to a porous surface with OP-1. Clin Orthop 2003;417:41-49.
25. Jensen TB, Overgaard S, Lind M, Rahbek O, Bunger C, Soballe K. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop Scand 2002;73:31-39.
26. McGee MA, Findlay DM, Howie DW, Carbone A, Ward P, Stamenkov R, Page TT, Bruce WJ, Wildenauer CI, Toth C. The use of OP-1 in femoral impaction grafting in a sheep model. J Orthop Res 2004;22:1008-1015.
27. Hentunen TA, Lakkakorpi PT, Tuukkanen J, Lehenkari PP, Sampath TK, Vaananen HK. Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption. Biochem Biophys Res Commun 1995;209:433-443.
28. Arts JJ, Gardeniers JW, Welten ML, Verdonschot N, Schreurs BW, Buma P. No negative effects of bone impaction grafting with bone and ceramic mixtures. Clin Orthop Relat Res 2005;438:239-247.
29. Van Der Donk S, Weernink T, Buma P, Aspenberg P, Slooff TJ, Schreurs BW. Rinsing morselized allografts improves bone and tissue ingrowth. Clin Orthop 2003;408:302-310.
30. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop 1994;301:302-312.
31. D'Antonio JA, Capello WN, Borden LS, Bargar WL, Bierbaum BF, Boettcher WG, Steinberg ME, Stulberg SD, Wedge JH. Classification and management of acetabular abnormalities in total hip arthroplasty. Clin Orthop Relat Res 1989;243:126-137.
32. Bergmann G, Siraky J, Rohlmann A, Koelbel R. A comparison of hip joint forces in sheep, dog and man. J Biomech 1984;17:907-921.
33. Takita H, Vehof JW, Jansen JA, Yamamoto M, Tabata Y, Tamura M, Kuboki Y. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats. J Biomed Mater Res A 2004;71:181-189.
34. Vehof JW, Mahmood J, Takita H, van't Hof MA, Kuboki Y, Spauwen PH, Jansen JA. Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. Plast Reconstr Surg 2001;108:434-443.
35. Lamerigts NM, Buma P, Aspenberg P, Schreurs BW, Slooff TJ. Role of growth factors in the incorporation of unloaded bone allografts in the goat. Clin Orthop 1999;368:260-270.
36. Der Donk S, Verdonschot N, Schreurs BW, Buma P. Soft tissue movement and stress shielding do not affect bone ingrowth in the bone conduction chamber. Comp Med 2002;52:328-331.
37. Ripamonti U, Van Den Heever B, Crooks J, Tucker MM, Sampath TK, Rueger DC, Reddi AH. Long-term evaluation of bone formation by osteogenic protein 1 in the baboon and relative efficacy of bone-derived bone morphogenetic proteins delivered by irradiated xenogeneic collagenous matrices. J Bone Miner Res 2000;15:1798-1809.
38. Blokhuis TJ, den Boer FC, Bramer JA, Jenner JM, Bakker FC, Patka P, Haarman HJ. Biomechanical and histological aspects of fracture healing stimulated with osteogenic protein-1. Biomaterials 2001;22:725-730.
39. Karrholm J, Hourigan P, Timperley J, Razaznejad R. Mixing bone graft with OP-1 does not improve cup or stem fixation in revision surgery of the hip: 5-year follow-up of 10 acetabular and 11 femoral study cases and 40 control cases. Acta Orthop 2006;77:39-48.